Cours Neuropathix, Inc.
Actions
NPTX
US64132Q1094
Recherche biotechnologique et médicale
Dirigeants | Titre | Age | Depuis |
---|---|---|---|
Dean Petkanas
CEO | Chief Executive Officer | 60 | 25/07/18 |
Mark Corrao
DFI | Director of Finance/CFO | 67 | 25/07/18 |
William Kinney
CTO | Chief Tech/Sci/R&D Officer | 66 | 25/07/18 |
Administrateurs | Titre | Age | Depuis |
---|---|---|---|
Robert Malasek
BRD | Director/Board Member | 55 | 20/06/17 |
Timothy Scott
BRD | Director/Board Member | 71 | 25/07/18 |
Dean Petkanas
CEO | Chief Executive Officer | 60 | 25/07/18 |
Varia. 1 janv. | Capi. | |
---|---|---|
+3,91 % | 108 Md | |
+10,87 % | 104 Md | |
+1,28 % | 22,33 Md | |
-13,14 % | 22,19 Md | |
-7,05 % | 18,69 Md | |
-38,36 % | 17,74 Md | |
-10,66 % | 17,64 Md | |
+3,75 % | 14,05 Md | |
+36,70 % | 12,51 Md |